Cargando…

Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries

Worldwide, 230,000+ people die annually from asbestos-related diseases (ARDs). The World Health Organization (WHO) recommends that countries develop a National Asbestos Profile (NAP) to eliminate ARDs. For 195 countries, we assessed the global status of NAPs (A: bona fide NAP, B: proxy NAP, C: relev...

Descripción completa

Detalles Bibliográficos
Autores principales: Arachi, Diana, Furuya, Sugio, David, Annette, Mangwiro, Alexander, Chimed-Ochir, Odgerel, Lee, Kenneth, Tighe, Peter, Takala, Jukka, Driscoll, Tim, Takahashi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917934/
https://www.ncbi.nlm.nih.gov/pubmed/33673264
http://dx.doi.org/10.3390/ijerph18041804
_version_ 1783657812266582016
author Arachi, Diana
Furuya, Sugio
David, Annette
Mangwiro, Alexander
Chimed-Ochir, Odgerel
Lee, Kenneth
Tighe, Peter
Takala, Jukka
Driscoll, Tim
Takahashi, Ken
author_facet Arachi, Diana
Furuya, Sugio
David, Annette
Mangwiro, Alexander
Chimed-Ochir, Odgerel
Lee, Kenneth
Tighe, Peter
Takala, Jukka
Driscoll, Tim
Takahashi, Ken
author_sort Arachi, Diana
collection PubMed
description Worldwide, 230,000+ people die annually from asbestos-related diseases (ARDs). The World Health Organization (WHO) recommends that countries develop a National Asbestos Profile (NAP) to eliminate ARDs. For 195 countries, we assessed the global status of NAPs (A: bona fide NAP, B: proxy NAP, C: relevant published information, D: no relevant information) by national income (HI: high, UMI: upper-middle, LMI: lower-middle, LI: low), asbestos bans (banned, no-ban) and public data availability. Fourteen (7% of 195) countries were category A (having a bona fide NAP), while 98, 51 and 32 countries were categories B, C and D, respectively. Of the 14 category-A countries, 8, 3 and 3 were LMI, UMI and HI, respectively. Development of a bona fide NAP showed no gradient by national income. The proportions of countries having a bona fide NAP were similar between asbestos-banned and no-ban countries. Public databases useful for developing NAPs contained data for most countries. Irrespective of the status of national income or asbestos ban, most countries have not developed a NAP despite having the potential. The global status of NAP is suboptimal. Country-level data on asbestos and ARDs in public databases can be better utilized to develop NAPs for globally eliminating ARDs.
format Online
Article
Text
id pubmed-7917934
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79179342021-03-02 Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries Arachi, Diana Furuya, Sugio David, Annette Mangwiro, Alexander Chimed-Ochir, Odgerel Lee, Kenneth Tighe, Peter Takala, Jukka Driscoll, Tim Takahashi, Ken Int J Environ Res Public Health Article Worldwide, 230,000+ people die annually from asbestos-related diseases (ARDs). The World Health Organization (WHO) recommends that countries develop a National Asbestos Profile (NAP) to eliminate ARDs. For 195 countries, we assessed the global status of NAPs (A: bona fide NAP, B: proxy NAP, C: relevant published information, D: no relevant information) by national income (HI: high, UMI: upper-middle, LMI: lower-middle, LI: low), asbestos bans (banned, no-ban) and public data availability. Fourteen (7% of 195) countries were category A (having a bona fide NAP), while 98, 51 and 32 countries were categories B, C and D, respectively. Of the 14 category-A countries, 8, 3 and 3 were LMI, UMI and HI, respectively. Development of a bona fide NAP showed no gradient by national income. The proportions of countries having a bona fide NAP were similar between asbestos-banned and no-ban countries. Public databases useful for developing NAPs contained data for most countries. Irrespective of the status of national income or asbestos ban, most countries have not developed a NAP despite having the potential. The global status of NAP is suboptimal. Country-level data on asbestos and ARDs in public databases can be better utilized to develop NAPs for globally eliminating ARDs. MDPI 2021-02-12 2021-02 /pmc/articles/PMC7917934/ /pubmed/33673264 http://dx.doi.org/10.3390/ijerph18041804 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Arachi, Diana
Furuya, Sugio
David, Annette
Mangwiro, Alexander
Chimed-Ochir, Odgerel
Lee, Kenneth
Tighe, Peter
Takala, Jukka
Driscoll, Tim
Takahashi, Ken
Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
title Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
title_full Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
title_fullStr Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
title_full_unstemmed Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
title_short Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
title_sort development of the “national asbestos profile” to eliminate asbestos-related diseases in 195 countries
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917934/
https://www.ncbi.nlm.nih.gov/pubmed/33673264
http://dx.doi.org/10.3390/ijerph18041804
work_keys_str_mv AT arachidiana developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT furuyasugio developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT davidannette developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT mangwiroalexander developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT chimedochirodgerel developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT leekenneth developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT tighepeter developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT takalajukka developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT driscolltim developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries
AT takahashiken developmentofthenationalasbestosprofiletoeliminateasbestosrelateddiseasesin195countries